189 related articles for article (PubMed ID: 10665895)
1. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis.
Carmeli Y; Samore MH; Huskins C
Arch Intern Med; 1999 Nov; 159(20):2461-8. PubMed ID: 10665895
[TBL] [Abstract][Full Text] [Related]
2. [Vancomycin resistant enterococci in Austria].
Allerberger F; Lass-Flörl C; Dierich MP; Hirschl AM; Presterl E; Haas G; Klare I; Witte W
Wien Klin Wochenschr; 1997 May; 109(9):312-20. PubMed ID: 9265389
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin-resistant enterococcus in end-stage renal disease.
Brady JP; Snyder JW; Hasbargen JA
Am J Kidney Dis; 1998 Sep; 32(3):415-8. PubMed ID: 9740157
[TBL] [Abstract][Full Text] [Related]
4. The Risk Factors, Costs, and Survival Analysis of Invasive VRE Infections at a Medical Center in Eastern Taiwan.
Jiang HL; Zhou Z; Wang LS; Fang Y; Li YH; Chu CI
Int J Infect Dis; 2017 Jan; 54():18-24. PubMed ID: 27836794
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and Outcomes of Vancomycin-Resistant Enterococcus Infections in the U.S. Military Health System.
Stagliano DR; Susi A; Adams DJ; Nylund CM
Mil Med; 2021 Jan; 186(Suppl 1):100-107. PubMed ID: 33499465
[TBL] [Abstract][Full Text] [Related]
6. Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review.
de Bruin MA; Riley LW
BMC Infect Dis; 2007 Apr; 7():24. PubMed ID: 17425800
[TBL] [Abstract][Full Text] [Related]
7. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit.
Martínez JA; Ruthazer R; Hansjosten K; Barefoot L; Snydman DR
Arch Intern Med; 2003 Sep; 163(16):1905-12. PubMed ID: 12963563
[TBL] [Abstract][Full Text] [Related]
8. Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci.
Chavers LS; Moser SA; Funkhouser E; Benjamin WH; Chavers P; Stamm AM; Waites KB
Microb Drug Resist; 2003; 9 Suppl 1():S69-77. PubMed ID: 14633370
[TBL] [Abstract][Full Text] [Related]
9. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
Bhavnani SM; Drake JA; Forrest A; Deinhart JA; Jones RN; Biedenbach DJ; Ballow CH
Diagn Microbiol Infect Dis; 2000 Mar; 36(3):145-58. PubMed ID: 10729656
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of vancomycin-resistant enterococcus (VRE) infection among patients hospitalized for inflammatory bowel disease in the United States.
Nguyen GC; Leung W; Weizman AV
Inflamm Bowel Dis; 2011 Jun; 17(6):1338-42. PubMed ID: 21560197
[TBL] [Abstract][Full Text] [Related]
11. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin-resistant enterococci (VRE) outbreak at a university hospital in Kitakyushu, Japan: case-control studies.
Hoshuyama T; Moriguchi H; Muratani T; Matsumoto T
J Infect Chemother; 2008 Oct; 14(5):354-60. PubMed ID: 18936888
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin-resistant enterococci, colonizing the intestinal tract of patients in a university hospital in Greece.
Metallidis S; Chatzidimitriou M; Tsona A; Bisiklis A; Lazaraki G; Koumentaki E; Gikas A; Alexiou-Daniel S; Nikolaidis P
Braz J Infect Dis; 2006 Jun; 10(3):179-84. PubMed ID: 17568849
[TBL] [Abstract][Full Text] [Related]
14. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units.
Fridkin SK; Edwards JR; Courval JM; Hill H; Tenover FC; Lawton R; Gaynes RP; McGowan JE;
Ann Intern Med; 2001 Aug; 135(3):175-83. PubMed ID: 11487484
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin-resistant enterococci.
Rubinstein E; Keynan Y
Crit Care Clin; 2013 Oct; 29(4):841-52. PubMed ID: 24094380
[TBL] [Abstract][Full Text] [Related]
16. Substantially increased faecal carriage of vancomycin-resistant enterococci in a tertiary Greek hospital after a 4 year time interval.
Sofianou D; Pournaras S; Giosi M; Polyzou A; Maniatis AN; Tsakris A
J Antimicrob Chemother; 2004 Jul; 54(1):251-4. PubMed ID: 15163658
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin-resistant-enterococci--colonization of 24 patients on a pediatric oncology unit.
Schuster F; Graubner UB; Schmid I; Weiss M; Belohradsky BH
Klin Padiatr; 1998; 210(4):261-3. PubMed ID: 9743963
[TBL] [Abstract][Full Text] [Related]
18. The clinical and molecular epidemiology of pre-transplant vancomycin-resistant enterococci colonization among liver transplant recipients.
Banach DB; Peaper DR; Fortune BE; Emre S; Dembry LM
Clin Transplant; 2016 Mar; 30(3):306-11. PubMed ID: 26780305
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and outcomes of vancomycin-resistant enterococcus infections: a systematic review and meta-analysis.
Eichel VM; Last K; Brühwasser C; von Baum H; Dettenkofer M; Götting T; Grundmann H; Güldenhöven H; Liese J; Martin M; Papan C; Sadaghiani C; Wendt C; Werner G; Mutters NT
J Hosp Infect; 2023 Nov; 141():119-128. PubMed ID: 37734679
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin-resistant enterococcus colonization and infection in children: six-year follow-up.
Özkaya-Parlakay A; Cengiz AB; Ceyhan M; Bağdat A; Barın-Kurtoğlu Ç; Gürbüz V; Aycan AE; Kara A
Turk J Pediatr; 2014; 56(6):618-25. PubMed ID: 26388592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
